Literature DB >> 8328988

Effect of human serum on the in vitro anti-HIV-1 activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding.

M Baba1, S Yuasa, T Niwa, M Yamamoto, S Yabuuchi, H Takashima, M Ubasawa, H Tanaka, T Miyasaka, R T Walker.   

Abstract

Several derivatives of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) were examined for their inhibitory effects on the replication of human immunodeficiency virus type 1 (HIV-1) in MT-4 cells in the presence of various concentrations (10-50%) of human serum (HS). Although all HEPT derivatives proved to be highly potent inhibitors of HIV-1 in the presence of 10% fetal bovine serum, some of them were less inhibitory to HIV-1 replication in the presence of HS. The HEPT derivatives were found to be highly bound to HS proteins. Both the anti-HIV-1 activity and HS protein binding of the compounds appeared to be related to their lipophilicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8328988     DOI: 10.1016/0006-2952(93)90232-l

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Rational dose selection for a nonnucleoside reverse transcriptase inhibitor through use of population pharmacokinetic modeling and Monte Carlo simulation.

Authors:  G L Drusano; K H P Moore; J P Kleim; W Prince; A Bye
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 2.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

3.  Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1.

Authors:  G M Szczech; P Furman; G R Painter; D W Barry; K Borroto-Esoda; T B Grizzle; M R Blum; J Sommadossi; R Endoh; T Niwa; M Yamamoto; C Moxham
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

Review 4.  Limitations of drug concentrations used in cell culture studies for understanding clinical responses of NSAIDs.

Authors:  Garry G Graham; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2021-09-12       Impact factor: 4.473

5.  Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro.

Authors:  M Baba; S Shigeta; S Yuasa; H Takashima; K Sekiya; M Ubasawa; H Tanaka; T Miyasaka; R T Walker; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.